Funded Tech Companies
ImmPACT Bio USA
Wondering who provided funding to ImmPACT Bio USA? Bukwang Pharmaceutical, Novartis Venture Fund and OrbiMed joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
ImmPACT Bio USA
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/28/2022
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Kendall
VP - R & D
Frank Calzone
Company Investors
- Bukwang Pharmaceutical
- Novartis Venture Fund
- OrbiMed
- venBio (Richard Gaster)
- Foresite Capital (James Tananbaum)
- Decheng Capital (Min Cui)
- RM Global Partners
- Surveyor Capital
- Takeda Ventures
- Johnson & Johnson Development Corporation
- Hayan Health Networks
- JVC Investment Partners
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs